Xian Gmei Li

Corporate Secretary at MICROPORT CARDIOFLOW MEDTECH CORPORATION

Health Technology

Energy Minerals

Consumer Services

Profile

Xian Gmei Li is currently a Joint Secretary at MicroPort CardioFlow Medtech Corp.
She previously worked as a Senior Manager at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and as a Manager-Investor Relations at Sinopec Shanghai Petrochemical Co., Ltd.
Ms. Li received an undergraduate degree from Zhengzhou University in 2002.

Xian Gmei Li active positions

Companies	Position	Start
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Corporate Secretary	2020-10-26

All active positions of Xian Gmei Li

Former positions of Xian Gmei Li

Companies	Position	End
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Corporate Officer/Principal	2019-12-31
SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED	Investor Relations Contact	2014-11-30

See the detail of Xian Gmei Li's experience

Training of Xian Gmei Li

Zhengzhou University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Xian Gmei Li's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED	Energy Minerals
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Health Technology

Private companies	1
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Health Technology